{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:13:34Z","timestamp":1791922414308,"version":"4.3.4"},"reference-count":25,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost\u2010effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The evaluation included a literature review, disease modelling to assess dose timing, a health economic analysis and an ethical review addressing vaccine acceptance and equitable access.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Varicella vaccines are safe and highly effective, providing near\u2010complete protection against severe disease requiring hospitalisation when two doses are given. Modelling indicates that virus circulation could be eliminated within 2\u20133\u2009years with high coverage and catch\u2010up vaccination, also protecting unvaccinated and immunocompromised individuals of all ages through population immunity. Two doses are recommended at 18\u2009months and 7\u20138\u2009years, both co\u2010administered with MMR. This schedule ensures durable immunity and high acceptance. Health economic analyses show the programme would be cost saving.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Following PHAS's evaluation, the Swedish government has decided to include varicella vaccination in the NIP from 2027, with catch\u2010up vaccination for susceptible individuals up to 18\u2009years, implemented primarily through the child and school health services to ensure equitable access.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/apa.70497","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T04:25:58Z","timestamp":1774585558000},"page":"2460-2465","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme"],"prefix":"10.1111","volume":"115","author":[{"given":"Annika","family":"Ersson","sequence":"first","affiliation":[{"name":"Department of Public Health Analysis and Data Management Public Health Agency of Sweden  Solna Sweden"},{"name":"Department of Communicable Disease Control and Prevention Region J\u00e4mtland\u2010 H\u00e4rjedalen  \u00d6stersund Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Johansen","sequence":"additional","affiliation":[{"name":"Department of Public Health Analysis and Data Management Public Health Agency of Sweden  Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4522-3078","authenticated-orcid":false,"given":"S\u00f6ren","family":"Andersson","sequence":"additional","affiliation":[{"name":"Department of Public Health Analysis and Data Management Public Health Agency of Sweden  Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"4","key":"e_1_2_13_2_1","first-page":"1","article-title":"Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin M.","year":"2007","journal-title":"MMWR Recommendations and Reports"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2007.126243"},{"issue":"1","key":"e_1_2_13_4_1","first-page":"41","article-title":"Canada's First Universal Varicella Immunization Program: Lessons From Prince Edward Island","volume":"14","author":"Sweet L.","year":"2003","journal-title":"Canadian Journal of Infectious Diseases"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-013-1789-z"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.09.024"},{"key":"e_1_2_13_7_1","unstructured":"Directorate of Health I National Childhood Vaccination Program in Iceland as of January 2025(2025) https:\/\/assets.ctfassets.net\/8k0h54kbe6bj\/3A7RiXYwzHUQVblbldyiqB\/0e1145516f461f0c044604f8f077f85b\/Almennar_bolusetningar_barna_fr__1._jan_ar_2025_ENSKA.pdf."},{"key":"e_1_2_13_8_1","unstructured":"Folkh\u00e4lsomyndigheten \u201cEvaluation of an Introduction of Vaccination Against Varicella in the Swedish National Vaccination Programme for Children\u2014Summary of Evidence \u201d(2024) https:\/\/www.folkhalsomyndigheten.se\/publikationer\u2010och\u2010material\/publikationsarkiv\/e\/evaluation\u2010of\u2010an\u2010introduction\u2010of\u2010vaccination\u2010against\u2010varicella\u2010in\u2010the\u2010swedish\u2010national\u2010vaccination\u2010programme\u2010for\u2010children\u2010summary\u2010of\u2010evidence\/."},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1957-5"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.08.012"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2006.07.012"},{"key":"e_1_2_13_12_1","unstructured":"Folkh\u00e4lsomyndigheten \u201cHealth Economic Evaluation of Varicella Vaccination Within the Swedish National Vaccination Programme for Children \u201d(2024) https:\/\/www.folkhalsomyndigheten.se\/contentassets\/3c536584611845bfaa4d91e11f19ec62\/health\u2010economic\u2010evaluation\u2010varicella\u2010vaccination\u2010programme\u2010children.pdf."},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1480283"},{"issue":"35","key":"e_1_2_13_14_1","first-page":"2500077","article-title":"Herpes Zoster Incidence in Adults Aged\u2009\u2265\u200920\u2009Years in Finland, 2015 to 2023: A Population\u2010Based Register Study","volume":"30","author":"Juutinen A.","year":"2025","journal-title":"Euro Surveillance"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586\u2010025\u201008800\u2010x"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.5013"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010024\u201003201\u20105"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.07.010"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2085"},{"key":"e_1_2_13_20_1","volume-title":"Systematic Review of Available Evidence on Effectiveness and Duration of Protection of Varicella Vaccines","author":"World Health Organization","year":"2014"},{"issue":"25","key":"e_1_2_13_21_1","first-page":"265","article-title":"Varicella and Herpes Zoster Vaccines: WHO Position Paper 2014","volume":"89","author":"World Health Organization","year":"2014","journal-title":"Weekly Epidemiological Record"},{"key":"e_1_2_13_22_1","unstructured":"European Centre for Disease Prevention and Control \u201cVaccine Scheduler: ECDC \u201dhttps:\/\/vaccine\u2010schedule.ecdc.europa.eu\/."},{"issue":"32","key":"e_1_2_13_23_1","article-title":"Impact of Universal Two\u2010Dose Vaccination on Varicella Epidemiology in Navarre, Spain, 2006 to 2012","volume":"18","author":"Garcia Cenoz M.","year":"2013","journal-title":"Euro Surveillance"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.140078"},{"key":"e_1_2_13_25_1","unstructured":"\u201cIndependent Report: JCVI Statement on a Childhood Varicella (Chickenpox) Vaccination Programme \u201d(2023) https:\/\/www.gov.uk\/government\/publications\/childhood\u2010varicella\u2010vaccination\u2010programme\u2010jcvi\u2010advice\u201014\u2010november\u20102023\/jcvi\u2010statement\u2010on\u2010a\u2010childhood\u2010varicella\u2010chickenpox\u2010vaccination\u2010programme."},{"key":"e_1_2_13_26_1","unstructured":"Statens Medicinsk\u2010Etiska R\u00e5d S \u201cVaccination mot vattkoppor och b\u00e4ltros \u2013 etisk analys \u201d(2024) https:\/\/smer.se\/wp\u2010content\/uploads\/2024\/05\/smer\u2010etisk\u2010analys\u2010av\u2010vaccination\u2010mot\u2010vattkoppor\u2010och\u2010baltros\u2010webb.pdf."}],"container-title":["Acta Paediatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apa.70497","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/apa.70497","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apa.70497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:16:14Z","timestamp":1791879374000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apa.70497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1111\/apa.70497"],"URL":"https:\/\/doi.org\/10.1111\/apa.70497","archive":["Portico"],"relation":{},"ISSN":["0803-5253","1651-2227"],"issn-type":[{"value":"0803-5253","type":"print"},{"value":"1651-2227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"2025-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}